We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-2 of 2

Article claims FDA “provides scant oversight” in medical device monitoring
  • Shook Hardy & Bacon LLP
  • USA
  • November 11 2010

According to a recent article on the effectiveness of post-market surveillance, medical device manufacturers "often fail to properly conduct safety studies" and the Food and Drug Administration (FDA) "provides scant oversight" in post-approval monitoring of these devices.